These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
23. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study. Attems J; Jellinger KA Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019 [TBL] [Abstract][Full Text] [Related]
24. APOE, vascular pathology, and the AD brain. Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796 [TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease and the quest for its biological measures. Praticò D J Alzheimers Dis; 2013; 33 Suppl 1():S237-41. PubMed ID: 22695619 [TBL] [Abstract][Full Text] [Related]
26. Pathology and pathophysiology of vascular cognitive impairment. A critical update. Jellinger KA Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978 [TBL] [Abstract][Full Text] [Related]
27. Amyloid beta and APP as biomarkers for Alzheimer's disease. Zetterberg H; Blennow K; Hanse E Exp Gerontol; 2010 Jan; 45(1):23-9. PubMed ID: 19698775 [TBL] [Abstract][Full Text] [Related]
28. Tangle-associated neuritic clusters. A new lesion in Alzheimer's disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with beta/A4. Munoz DG; Wang D Am J Pathol; 1992 May; 140(5):1167-78. PubMed ID: 1580329 [TBL] [Abstract][Full Text] [Related]
29. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Schwab C; Hosokawa M; McGeer PL Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802 [TBL] [Abstract][Full Text] [Related]